Bowman layer transplantation effective in advanced keratoconus November 01, 2016By Laird HarrisonIsolated Bowman layer transplantation can reduce and stabilize corneal ectasia in eyes with progressive advanced keratoconus, researchers said. “It flattens the cornea into a more normal position,” said Jack Parker, MD, a researcher at the Netherlands Institute for Innovative Ocular Surgery (NIIOS) in Rotterdam, The Netherlands. “It doesn’t give them perfect vision, but it keeps them from getting worse. It lets them to continue wearing their contact lenses.”
In this issue
Achieving physiologic restoration in dry eye November 01, 2016By Laura M. Periman MDTear osmolarity testing provides clinicians the opportunity to detect disease and select treatments to restore ocular surface health. Hypochlorous acid eyelid wash reduces bacterial load November 01, 2016By Fred GebhartResearchers studied the magnitude of bacterial load reduction on the surface of the skin 20 minutes after application of saline containing 0.01% pure hypochlorous acid as the preservative to the skin below the lower eyelid. Novel device provides rapid measure of tear osmolarity November 01, 2016By Nancy GrovesA new handheld, tear osmolarity device could enhance the convenience and reliability of dry eye screening and monitoring and be more affordable for many practices. Topical ENaC blocker serves as novel approach to tear film November 01, 2016By Lynda ChartersA novel potent epithelial sodium channel blocker seems to be a safe and well-tolerated therapy in patients with symptoms of mild-to-moderate dry eye disease compared with placebo. Toric trifocal IOL brings expanded range of functional vision to larger patient populationTrifocal IOLs can provide good uncorrected vision at near, intermediate, and far. Outcomes in a series of 30 patients show that a toric version of a trifocal IOL (AT Lisa tri 939MP, Carl Zeiss Meditec) delivers those benefits for patients with > 1 D of corneal astigmatism. Glaucoma micro-stent’s 2-year data promising November 01, 2016By Laird HarrisonTake-home: With the approval of a new surgical device aimed at lowering IOP, surgeons explore benefits of micro-stent implantation. Re-bubbling cases show a higher endothelial cell loss post-DMEKAnalyses of data from 293 eyes undergoing uncomplicated Descemet membrane endothelial keratoplasty (DMEK) show that endothelial cell loss is greater in eyes that undergo a single re-bubbling for graft separation. The study, however, does not establish a causal association. New dry eye treatment demonstrates rapid onset symptomatic reliefResults from the Phase 3 OPUS-3 trial provide evidence confirming a benefit of lifitegrast ophthalmic solution 5.0% (Xiidra, Shire) for significantly improving dry eye disease-related symptoms, as measured by Eye Dryness Score. Intense pulsed light shows therapeutic potential for MGD
November 01, 2016A series of treatments using intense pulsed light with optimal pulse technology may show potential in patients with meibomian gland dysfunction.
Are we ophthalmologists in the eye of the storm?This meteorological phenomenon is considered to have given rise to one of the most commonly misused phrases in the English language. Some people think the phrase means that the situation is a tumultuous one, as when The Economist magazine reported: “French bank shares, which have been in the eye of the storm, recovered sharply (BNP Paribas was up 13% on the day while Societe Generale rose by 5%).” Sustained-release dexamethasone depot effective in lowering fluorescein staining November 01, 2016By Nancy GrovesA dropless option for steroid therapy showed encouraging results in a phase II safety and efficacy study in patients with inflammatory dry eye disease. Vectored thermal pulsation delivers long-lasting MGD improvementFollow-up from a study enrolling 200 patients with meibomian gland dysfuction showed a single treatment with vectored thermal pulsation afforded improvements in symptoms and meibomian gland function. Semifluorinated alkane technology brings advantages for topical therapySemifluorinated alkane technology has novel physicochemical properties that explain its benefits as an ocular lubricant and support its use for developing a well-tolerated, preservative-free, multidose preparation of cyclosporine. Why the election will be decided by ophthalmologists November 01, 2016By Jolie HigaziLearn why ophthalmologists are tasked with the most important profession during this presidential election!